rs148468628

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2

The NM_005199.5(CHRNG):​c.125G>A​(p.Arg42Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00287 in 1,614,220 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R42W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0025 ( 4 hom., cov: 33)
Exomes 𝑓: 0.0029 ( 7 hom. )

Consequence

CHRNG
NM_005199.5 missense

Scores

5
9
4

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:10

Conservation

PhyloP100: 7.76

Publications

7 publications found
Variant links:
Genes affected
CHRNG (HGNC:1967): (cholinergic receptor nicotinic gamma subunit) The mammalian muscle-type acetylcholine receptor is a transmembrane pentameric glycoprotein with two alpha subunits, one beta, one delta, and one epsilon (in adult skeletal muscle) or gamma (in fetal and denervated muscle) subunit. This gene, which encodes the gamma subunit, is expressed prior to the thirty-third week of gestation in humans. The gamma subunit of the acetylcholine receptor plays a role in neuromuscular organogenesis and ligand binding and disruption of gamma subunit expression prevents the correct localization of the receptor in cell membranes. Mutations in this gene cause Escobar syndrome and a lethal form of multiple pterygium syndrome. Muscle-type acetylcholine receptor is the major antigen in the autoimmune disease myasthenia gravis.[provided by RefSeq, Sep 2009]
CHRNG Gene-Disease associations (from GenCC):
  • autosomal recessive multiple pterygium syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Orphanet
  • CHRNG-associated hypo-akinesia disorder of prenatal onset
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • lethal multiple pterygium syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • transient neonatal myasthenia gravis
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.10330105).
BP6
Variant 2-232540061-G-A is Benign according to our data. Variant chr2-232540061-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 376837.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00252 (384/152344) while in subpopulation NFE AF = 0.00422 (287/68022). AF 95% confidence interval is 0.00382. There are 4 homozygotes in GnomAd4. There are 187 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005199.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHRNG
NM_005199.5
MANE Select
c.125G>Ap.Arg42Gln
missense
Exon 2 of 12NP_005190.4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHRNG
ENST00000651502.1
MANE Select
c.125G>Ap.Arg42Gln
missense
Exon 2 of 12ENSP00000498757.1P07510-1
CHRNG
ENST00000389492.3
TSL:1
c.125G>Ap.Arg42Gln
missense
Exon 2 of 11ENSP00000374143.3P07510-2
CHRNG
ENST00000485094.1
TSL:1
n.146G>A
non_coding_transcript_exon
Exon 2 of 5

Frequencies

GnomAD3 genomes
AF:
0.00254
AC:
386
AN:
152226
Hom.:
4
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000458
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00262
Gnomad ASJ
AF:
0.00691
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000847
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00423
Gnomad OTH
AF:
0.00192
GnomAD2 exomes
AF:
0.00229
AC:
576
AN:
251312
AF XY:
0.00209
show subpopulations
Gnomad AFR exome
AF:
0.000369
Gnomad AMR exome
AF:
0.00188
Gnomad ASJ exome
AF:
0.00506
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.000647
Gnomad NFE exome
AF:
0.00374
Gnomad OTH exome
AF:
0.00212
GnomAD4 exome
AF:
0.00291
AC:
4251
AN:
1461876
Hom.:
7
Cov.:
33
AF XY:
0.00278
AC XY:
2023
AN XY:
727240
show subpopulations
African (AFR)
AF:
0.000448
AC:
15
AN:
33480
American (AMR)
AF:
0.00203
AC:
91
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00528
AC:
138
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.000468
AC:
25
AN:
53420
Middle Eastern (MID)
AF:
0.000693
AC:
4
AN:
5768
European-Non Finnish (NFE)
AF:
0.00340
AC:
3785
AN:
1112000
Other (OTH)
AF:
0.00320
AC:
193
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
287
574
860
1147
1434
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
134
268
402
536
670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00252
AC:
384
AN:
152344
Hom.:
4
Cov.:
33
AF XY:
0.00251
AC XY:
187
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.000457
AC:
19
AN:
41580
American (AMR)
AF:
0.00261
AC:
40
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00691
AC:
24
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.000847
AC:
9
AN:
10624
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00422
AC:
287
AN:
68022
Other (OTH)
AF:
0.00190
AC:
4
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
19
38
56
75
94
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00312
Hom.:
3
Bravo
AF:
0.00240
TwinsUK
AF:
0.00405
AC:
15
ALSPAC
AF:
0.00311
AC:
12
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00326
AC:
28
ExAC
AF:
0.00247
AC:
300
EpiCase
AF:
0.00354
EpiControl
AF:
0.00391

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not provided (6)
-
-
2
not specified (2)
-
1
-
Autosomal recessive multiple pterygium syndrome (1)
-
-
1
CHRNG-related disorder (1)
-
-
1
Lethal multiple pterygium syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.54
BayesDel_addAF
Benign
-0.028
T
BayesDel_noAF
Pathogenic
0.19
CADD
Uncertain
24
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.83
D
Eigen
Uncertain
0.50
Eigen_PC
Uncertain
0.32
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Benign
0.84
T
M_CAP
Uncertain
0.24
D
MetaRNN
Benign
0.10
T
MetaSVM
Uncertain
0.75
D
MutationAssessor
Pathogenic
4.1
H
PhyloP100
7.8
PrimateAI
Benign
0.42
T
PROVEAN
Uncertain
-3.4
D
REVEL
Pathogenic
0.73
Sift
Uncertain
0.0030
D
Sift4G
Uncertain
0.0050
D
Polyphen
1.0
D
Vest4
0.87
MVP
0.82
MPC
0.45
ClinPred
0.080
T
GERP RS
4.0
PromoterAI
0.00060
Neutral
Varity_R
0.75
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148468628; hg19: chr2-233404771; COSMIC: COSV51330914; COSMIC: COSV51330914; API